NCT06903481

Brief Summary

This retrospective observational study aims to characterize the prevalence and clinical features of obstructive sleep apnea (OSA) phenotypes and develop a rater-independent algorithm for automated OSA phenotyping, improving diagnosis and personalized treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,055

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 30, 2025

Completed
Last Updated

March 30, 2025

Status Verified

March 1, 2025

Enrollment Period

2.6 years

First QC Date

March 24, 2025

Last Update Submit

March 24, 2025

Conditions

Keywords

Polysomnography (PSG) recordings

Outcome Measures

Primary Outcomes (1)

  • Phenotype characterization

    To characterize the prevalence and clinical features of distinct obstructive sleep apnea (OSA) phenotypes in a large, diverse patient population, polysomnography (PSG) recordings from two publicly available National Sleep Research Resource data collections are analyzed and compared to datasets from the University Hospital Basel (USB) and University Children's Hospital Basel (UKBB) to assess generalizability.

    2025

Secondary Outcomes (1)

  • Computer-aided phenotyping

    2025

Study Arms (2)

Adults

Adults who underwent polysomnography recordings at the University Hospital Basel in 2023.

Children and adolescents

Children and adolescents who underwent polysomnography recordings at the University Children's Hospital Basel between January 2022 to July 2024.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults who underwent polysomnography recordings at the University Hospital Basel in 2023, as well as children and adolescents who underwent polysomnography recordings at the University Children's Hospital Basel between January 2022 and July 2024. All patients have signed the general consent of the university hospital (UBS), resp. The university children's hospital (UKBB).

You may qualify if:

  • age 19 years and older (data from University Hospital Basel (USB))
  • age 18 years or younger (data from University Children's Hospital Basel (UKBB))
  • Epworth Sleepiness Scale (ESS) score available (USB only)
  • Diagnosis available (e.g. Obstructive sleep apnea (OSA), Central Sleep Apnea (CSA), Cheyne Stokes Breathing (CSR), ...)
  • signed written general consent

You may not qualify if:

  • history of treatment of sleep apnea
  • tracheostomy
  • current home oxygen therapy
  • decline to sign the written general consent, or absence of written general consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Children's Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

Location

University Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Matthias Herrmann, Dr. med.

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2025

First Posted

March 30, 2025

Study Start

January 1, 2022

Primary Completion

July 31, 2024

Study Completion

July 31, 2024

Last Updated

March 30, 2025

Record last verified: 2025-03

Locations